In medical terms, primary periodic paralysis is referred to as a spectrum of chronic genetic, neuromuscular disorders with autosomal dominant inheritance.1-4
Primary periodic paralysis is very rare, affecting about 5,000 to 6,000 individuals in the US, or about 3 in every 200,000 people. The most common forms of the disease are hypokalemic and hyperkalemic primary periodic paralysis.5-9
KEVEYIS® (dichlorphenamide) 50 mg tablets is indicated for the treatment of:12
In clinical studies, the most common side effects of KEVEYIS were a numbness or tingling, difficulty thinking and paying attention, changes in taste, and confusion. These are not all of the possible side effects that you may experience with KEVEYIS. Talk to your doctor if you have any symptoms that bother you or do not go away.
KEVEYIS is not for everyone. Do not take KEVEYIS if you:
Taking KEVEYIS may cause a drop in the amount of potassium (an electrolyte) in your body, which can lead to heart problems. Ask your doctor if you need to eat foods that contain high amounts of potassium while taking KEVEYIS.
Your body may produce too much acid or may not be able to remove enough acid from body fluids while taking KEVEYIS. Your doctor will run tests on a regular basis to check for signs of acid buildup and may reduce your dose or stop your treatment with KEVEYIS.
KEVEYIS may also increase the risk of falls, especially in elderly patients and patients taking high doses of KEVEYIS. Use caution when driving, operating machinery, or performing any other hazardous activities while taking KEVEYIS, as this medication may cause drowsiness.
For additional KEVEYIS important safety information, please see full Prescribing Information (PDF).